174 related articles for article (PubMed ID: 20014790)
21. Bis-methionine ligation to heme iron in mutants of cytochrome b562. 2. Characterization by NMR of heme-ligand interactions.
Barker PD; Freund SM
Biochemistry; 1996 Oct; 35(42):13627-35. PubMed ID: 8885842
[TBL] [Abstract][Full Text] [Related]
22. Improved synthesis of chiral pyrrolidine inhibitors and their binding properties to neuronal nitric oxide synthase.
Xue F; Kraus JM; Labby KJ; Ji H; Mataka J; Xia G; Li H; Delker SL; Roman LJ; Martásek P; Poulos TL; Silverman RB
J Med Chem; 2011 Sep; 54(18):6399-403. PubMed ID: 21809851
[TBL] [Abstract][Full Text] [Related]
23. Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase.
Cinelli MA; Li H; Pensa AV; Kang S; Roman LJ; Martásek P; Poulos TL; Silverman RB
J Med Chem; 2015 Nov; 58(21):8694-712. PubMed ID: 26469213
[TBL] [Abstract][Full Text] [Related]
24. A conserved Val to Ile switch near the heme pocket of animal and bacterial nitric-oxide synthases helps determine their distinct catalytic profiles.
Wang ZQ; Wei CC; Sharma M; Pant K; Crane BR; Stuehr DJ
J Biol Chem; 2004 Apr; 279(18):19018-25. PubMed ID: 14976216
[TBL] [Abstract][Full Text] [Related]
25. Role of zinc in isoform-selective inhibitor binding to neuronal nitric oxide synthase .
Delker SL; Xue F; Li H; Jamal J; Silverman RB; Poulos TL
Biochemistry; 2010 Dec; 49(51):10803-10. PubMed ID: 21138269
[TBL] [Abstract][Full Text] [Related]
26. Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping.
Ji H; Li H; Martásek P; Roman LJ; Poulos TL; Silverman RB
J Med Chem; 2009 Feb; 52(3):779-97. PubMed ID: 19125620
[TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of de novo cytochromes c.
Ishida M; Dohmae N; Shiro Y; Oku T; Iizuka T; Isogai Y
Biochemistry; 2004 Aug; 43(30):9823-33. PubMed ID: 15274636
[TBL] [Abstract][Full Text] [Related]
28. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
Hah JM; Martásek P; Roman LJ; Silverman RB
J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
[TBL] [Abstract][Full Text] [Related]
29. Crystal structures of ferrous and CO-, CN(-)-, and NO-bound forms of rat heme oxygenase-1 (HO-1) in complex with heme: structural implications for discrimination between CO and O2 in HO-1.
Sugishima M; Sakamoto H; Noguchi M; Fukuyama K
Biochemistry; 2003 Aug; 42(33):9898-905. PubMed ID: 12924938
[TBL] [Abstract][Full Text] [Related]
30. Pyrazoles and pyrazolines as neural and inducible nitric oxide synthase (nNOS and iNOS) potential inhibitors (III).
Carrión MD; López Cara LC; Camacho ME; Tapias V; Escames G; Acuña-Castroviejo D; Espinosa A; Gallo MA; Entrena A
Eur J Med Chem; 2008 Nov; 43(11):2579-91. PubMed ID: 18325637
[TBL] [Abstract][Full Text] [Related]
31. In search of potent and selective inhibitors of neuronal nitric oxide synthase with more simple structures.
Jing Q; Li H; Fang J; Roman LJ; Martásek P; Poulos TL; Silverman RB
Bioorg Med Chem; 2013 Sep; 21(17):5323-31. PubMed ID: 23867386
[TBL] [Abstract][Full Text] [Related]
32. Insights into the structural determinants for selective inhibition of nitric oxide synthase isoforms.
Oliveira BL; Moreira IS; Fernandes PA; Ramos MJ; Santos I; Correia JD
J Mol Model; 2013 Apr; 19(4):1537-51. PubMed ID: 23263357
[TBL] [Abstract][Full Text] [Related]
33. Selective monocationic inhibitors of neuronal nitric oxide synthase. Binding mode insights from molecular dynamics simulations.
Huang H; Ji H; Li H; Jing Q; Labby KJ; Martásek P; Roman LJ; Poulos TL; Silverman RB
J Am Chem Soc; 2012 Jul; 134(28):11559-72. PubMed ID: 22731813
[TBL] [Abstract][Full Text] [Related]
34. Spectroscopic evidence supporting neutral thiol ligation to ferrous heme iron.
Sono M; Sun S; Modi A; Hargrove MS; Molitor B; Frankenberg-Dinkel N; Dawson JH
J Biol Inorg Chem; 2018 Oct; 23(7):1085-1092. PubMed ID: 30251130
[TBL] [Abstract][Full Text] [Related]
35. Recent advances toward improving the bioavailability of neuronal nitric oxide synthase inhibitors.
Huang H; Silverman RB
Curr Top Med Chem; 2013; 13(7):803-12. PubMed ID: 23578024
[TBL] [Abstract][Full Text] [Related]
36. Heme distortion modulated by ligand-protein interactions in inducible nitric-oxide synthase.
Li D; Stuehr DJ; Yeh SR; Rousseau DL
J Biol Chem; 2004 Jun; 279(25):26489-99. PubMed ID: 15066989
[TBL] [Abstract][Full Text] [Related]
37. Cyclopropyl- and methyl-containing inhibitors of neuronal nitric oxide synthase.
Li H; Xue F; Kraus JM; Ji H; Labby KJ; Mataka J; Delker SL; Martásek P; Roman LJ; Poulos TL; Silverman RB
Bioorg Med Chem; 2013 Mar; 21(5):1333-43. PubMed ID: 23352768
[TBL] [Abstract][Full Text] [Related]
38. Inactivation Mechanism of Neuronal Nitric Oxide Synthase by (
Yan L; Wang Y; Zhang S; Li X; Wei J; Wang Z; Liu Y
Inorg Chem; 2021 Jul; 60(13):9345-9358. PubMed ID: 34137256
[TBL] [Abstract][Full Text] [Related]
39. Copper(I) complex O(2)-reactivity with a N(3)S thioether ligand: a copper-dioxygen adduct including sulfur ligation, ligand oxygenation, and comparisons with all nitrogen ligand analogues.
Lee DH; Hatcher LQ; Vance MA; Sarangi R; Milligan AE; Sarjeant AA; Incarvito CD; Rheingold AL; Hodgson KO; Hedman B; Solomon EI; Karlin KD
Inorg Chem; 2007 Jul; 46(15):6056-68. PubMed ID: 17580938
[TBL] [Abstract][Full Text] [Related]
40. Structural basis for isoform-selective inhibition in nitric oxide synthase.
Poulos TL; Li H
Acc Chem Res; 2013 Feb; 46(2):390-8. PubMed ID: 23030042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
